Sign up to save your podcasts
Or
Share Discussing axSpA: JAKi cycling and long-term safety of bimekizumab in patients with axSpA or PsA
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Discussing axSpA: JAKi cycling and long-term safety of bimekizumab in patients with axSpA or PsA
Join Dr Sofia Ramiro and cohosts Professors Atul Deodhar, Hideto Kameda, and Xenofon Baraliakos for the latest episode of the discussing axSpA podcast on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest updates in axSpA.
In this episode, our faculty discusses two papers: the first assesses switching to secukinumab or cycling with other TNF inhibitors, and the second investigates long-term safety of bimekizumab in adult patients with axSpA or PsA.
View all episodes
By The Immune-Mediated Inflammatory Disease Forum
4.9
88 ratings
Join Dr Sofia Ramiro and cohosts Professors Atul Deodhar, Hideto Kameda, and Xenofon Baraliakos for the latest episode of the discussing axSpA podcast on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest updates in axSpA.
In this episode, our faculty discusses two papers: the first assesses switching to secukinumab or cycling with other TNF inhibitors, and the second investigates long-term safety of bimekizumab in adult patients with axSpA or PsA.
More shows like The IMID Forum
View all
JAMA Editors' Summary
135 Listeners
NEJM This Week
318 Listeners
Lupus Science and Medicine Podcast
15 Listeners
Rheumnow Podcast
124 Listeners
Pod Save America
86,713 Listeners
The Curbsiders Internal Medicine Podcast
3,328 Listeners
The Daily
110,969 Listeners
Core IM | Internal Medicine Podcast
1,111 Listeners
The Evidence Based Rheumatology Podcast
113 Listeners
ACR on Air
70 Listeners
Rheumatology For The Royal College
174 Listeners
ACR Journals On Air
19 Listeners
The Rest Is Politics: Leading
849 Listeners
The Lupus Forum
0 Listeners
The Rest Is Politics: US
2,215 Listeners